Multifactorial Secondary Autonomic Dysfunction (MSAD): A Cumulative-Injury and Autonomic-Reserve Framework for Complex Secondary Dysautonomia
Advances in Neurology and Neuroscience · 28.10.2026 · 09 (04) · 01-06
DOI: 10.33140/an.09.04.16 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Neurology and Neuroscience, online erschienen am 28.10.2026. Verfasst von Bruce H. Knox.
Abstract (Originalsprache)
Background
Autonomic disorders frequently affect cardiovascular, gastrointestinal, thermoregulatory, genitourinary, sleep, cognitive, and exercise domains. In some patients, no single cause adequately explains the onset, severity, fluctuation, and partial recovery of multisystem dysfunction. Multifactorial Secondary Autonomic Dysfunction (MSAD) has been proposed to describe a secondary dysautonomic phenotype in which cumulative physiological insults interact with limited autonomic reserve.
Objective
To refine MSAD into a journal-ready, falsifiable clinical framework that distinguishes hypotheses from established evidence and can be tested against recognised primary autonomic and neurodegenerative disorders. Approach: This conceptual review integrates the previously published MSAD framework and first-person longitudinal reports with contemporary literature on orthostatic hypotension, post-viral dysautonomia, cardiac surgery-related autonomic disturbance, autonomic rehabilitation, and the differential diagnosis of neurodegenerative autonomic failure. Proposed framework: MSAD is conceptualised as a threshold disorder of regulation rather than a single pathological lesion. The framework comprises: (1) objective confirmation of autonomic dysfunction; (2) mapping of affected autonomic domains; (3) longitudinal identification of potentially interacting infectious, inflammatory, haemodynamic, metabolic, medication-related, surgical, or deconditioning burdens; and (4) systematic differential diagnosis, including exclusion of primary neurodegenerative autonomic disorders when clinically indicated. Recovery, when it occurs, is predicted to be selective and asynchronous rather than uniform.
Implications
The model neither implies that all secondary dysautonomia is reversible nor establishes cumulative injury in any individual patient. Its value lies in organising complex histories, avoiding premature single-cause closure, identifying modifiable contributors, and generating testable longitudinal hypotheses.
Conclusion
MSAD is best regarded as an integrative clinical and research framework. Prospective cohorts, validated operational criteria, and biomarker studies are required before it can be considered a distinct diagnostic category.
Zitieren
APA
Knox, B. H. (2026). Multifactorial Secondary Autonomic Dysfunction (MSAD): A Cumulative-Injury and Autonomic-Reserve Framework for Complex Secondary Dysautonomia. Advances in Neurology and Neuroscience, 09(04), 01-06. https://doi.org/10.33140/an.09.04.16
Vancouver
Knox BH. Multifactorial Secondary Autonomic Dysfunction (MSAD): A Cumulative-Injury and Autonomic-Reserve Framework for Complex Secondary Dysautonomia. Advances in Neurology and Neuroscience. 2026;09(04):01-06. doi:10.33140/an.09.04.16
BibTeX
@article{Knox2026,
author = {Knox, Bruce H.},
title = {Multifactorial Secondary Autonomic Dysfunction (MSAD): A Cumulative-Injury and Autonomic-Reserve Framework for Complex Secondary Dysautonomia},
journal = {Advances in Neurology and Neuroscience},
year = {2026},
volume = {09},
number = {04},
pages = {01--06},
doi = {10.33140/an.09.04.16}
}
EUVIMED